HistoRx Names Bill Sullivan Senior Vice President, Diagnostic ...(ent. Mr. Sullivan brings to HistoRx ...)

Mr. Sullivan brings to HistoRx an accomplished management record, with more than 25 years of experience leading operations of technology-driven businesses in the in vitro diagnostics and medical devices industries. He was previously Vice President, Corporate Operations of Vermillion, Inc. (formerly Ciphergen Biosystems, Inc.); prior to that, he served as Vice President, Diagnostic Manufacturing at Visible Genetics and as Vice President, Operations at the Nichols Institute Diagnostics (a subsidiary of Quest Diagnostics), among positions with other diagnostics and medical device companies. Mr. Sullivan also served as a consultant to diagnostics and medical device companies, specializing in manufacturing operations for FDA-regulated facilities and products. He earned a B.A. from The College of the Holy Cross in Worcester, Massachusetts and pursued graduate studies in the Department of Pathology at the University of Pennsylvania.

About HistoRx ( http://www.historx.com )

HistoRx, Inc. is a leader in the emerging field of tissue-based diagnostic products for targeted patient treatment. HistoRx is developing and commercializing novel diagnostic products and services based on the company's pioneering AQUA(R) tissue biomarker analysis technology, which provides exceptional measurement and localization of protein biomarkers in their natural context within tissue. The proprietary AQUA(R) technology is the first platform capable of measuring biomarker concentration with subcellular resolution to generate more precise, efficient, and cost-effective answers about the safety and effectiveness of new therapeutics in development as well as enable the development of companion diagnostic tests for targeted therapies. HistoRx services are used by pharmaceutical and biotechnology companies throughout discovery research, preclinical studies, and clinical drug development. HistoRx also develops companion diagnos
'/>"/>